PHARMARISE HOLDINGS CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 656 JPY | +0.61% |
|
+0.15% | -0.61% |
| Sales 2022 | 51.61B 332M | Sales 2023 | 52.03B 334M | Capitalization | 5.76B 37.01M |
|---|---|---|---|---|---|
| Net income 2022 | 447M 2.87M | Net income 2023 | 333M 2.14M | EV / Sales 2022 | 0.25 x |
| Net Debt 2022 | 5.92B 38.05M | Net Debt 2023 | 4.4B 28.25M | EV / Sales 2023 | 0.2 x |
| P/E ratio 2022 |
20.1
x | P/E ratio 2023 |
22.7
x | Employees | 1,555 |
| Yield 2022 |
1.92% | Yield 2023 |
2.29% | Free-Float | 30.62% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.61% | ||
| 1 week | +0.15% | ||
| Current month | +0.31% | ||
| 1 month | -2.67% | ||
| 3 months | -4.09% | ||
| 6 months | +1.39% | ||
| Current year | -0.61% |
1 week
643.00
656.00
1 month
639.00665.00
Current year
638.00722.00
1 year
610.00722.00
3 years
605.00845.00
5 years
494.00851.00
10 years
456.00851.00
| Managers | Title | Age | Since |
|---|---|---|---|
Toshimichi Ohno
CEO | Chief Executive Officer | 74 | 84-05-31 |
Masayuki Akiyama
PSD | President | 57 | 97-01-31 |
Yutaka Numata
BRD | Director/Board Member | 60 | 12-01-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Toshimichi Ohno
CEO | Chief Executive Officer | 74 | 84-05-31 |
Sayoko Ohno
BRD | Director/Board Member | 74 | 84-05-31 |
Masayuki Akiyama
PSD | President | 57 | 97-01-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 10 M€ | +7.96% | ||
| 0.00% | 18 M€ | +16.15% | - | |
| 0.00% | 144,586 M€ | +13.76% | ||
| 0.00% | 66,066 M€ | +13.80% | - | |
| 0.00% | 20,721 M€ | +12.65% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-25 | 656 | +0.61% | 8 300 |
| 24-04-24 | 652 | 0.00% | 9,800 |
| 24-04-23 | 652 | +0.46% | 3,000 |
| 24-04-22 | 649 | 0.00% | 1,800 |
| 24-04-19 | 649 | +0.78% | 3,700 |
Delayed Quote Japan Exchange, April 25, 2024 at 02:00 am EDT
More quotes
Pharmarise Holdings Corporation is a Japan-based holding company primarily engaged in the dispensing pharmacy businesses. Along with its subsidiaries and associated companies, the Company operates in five business segments. The Dispensing Pharmacy segment is engaged in the operation of dispensing pharmacies, which prescribe medicines to general patients based on prescriptions issued by medical institutions. The Merchandising segment consists of the cosmetics sales business, the convenience store management business and the drug store management business. The Medical Document Storage and Management segment is engaged in the storage and management of paper medical records and X-ray films. The Medical Mall Management segment is a business related to medical malls operated at JR Tower Office Plaza Sapporo in JR Sapporo Station. Others segment includes temporary staffing business and sales of stationery.
Sector
Drug Retailers
Calendar
2024-07-10
- Q4 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -0.61% | 47.27M | |
| -15.24% | 8.24B | |
| +33.06% | 1.36B | |
| +7.36% | 427M | |
| +7.36% | 292M | |
| +13.33% | 230M | |
| -10.09% | 83.28M | |
| +19.97% | 59.98M |
- Stock Market
- Equities
- 2796 Stock
